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Impediments to successful gene transfer to the kidney in the directly target the relevant organ by transfer of immuno-
context of transplantation and how to overcome them. modulatory genes. Having access to an organ stored and
Background. Manipulation of the graft with immunosup- perfused under routine conditions of organ preservationpressive genes represents a novel approach to overcome the
presents a unique challenge to start exploring the realtoxicity of immunosuppressants currently used to prevent acute
potential for gene therapy in the clinical setting.rejection. Here we compared the efficiency of a non-viral versus
a viral technique of gene transfer to the kidney in the setting Crucial to the success of graft’s genetic manipulation
of isotransplantation and evaluated whether transfection with is the choice of the vector system. Non-viral vectors have
adenovirus encoding CTLA4Ig prolonged allograft survival. been utilized by pioneers in the field of gene transferMethods. Donor rat kidneys were perfused with a medium
due to the simplicity of their use, the ease of large-containing the cationic polymer polyethylenimine PEI 25k
complexed to a vector coding for the -galactosidase (-gal) scale production, and lack of specific immune response.
gene or with a replication-deficient adenovirus encoding the Previous studies have shown that injection into the renal
-gal gene (AdCMV-gal; 1109 pfu) before isotransplanta- artery of the cationic polymer polyethylenimine (PEI
tion. In another set of experiments, donor kidneys were per-
25k), complexed with a reporter gene, effectively trans-fused with an adenovirus encoding the murine CTLA4Ig gene
fected the kidney mainly at the level of proximal tubuli,(AdmCTLA4Ig; 1x109 pfu) before allotransplantation.
Results. Perfusion with PEI/DNA complexes resulted in but the transfection efficiency was unacceptably low [2].
large areas of hypoperfusion, histology showed glomerular and An alternative to non-viral vectors is replication-defec-
tubular injury, capillary thrombosis, and complement activa- tive adenovirus that is able to infect non-dividing cellstion. Reperfusion with lower PEI/DNA ratio was possible but
quite effectively, transfecting cDNA up to 7–8 Kb, andno detectable transfection observed. In animals receiving ade-
have been successfully used for gene delivery to thenovirus, -gal activity increased with time and localized mainly
in proximal and distal tubular cells as documented by -gal transplant organ. For how long the gene of interest can
histochemistry and in situ hybridization. Adenovirus-mediated be expressed by the transfected organ is also an issue.
transduction of CTLA4Ig, a recombinant fusion protein that
Efficient adenovirus-mediated gene transfer of -galac-blocks T cell activation, resulted in a prolonged allograft sur-
tosidase into liver grafts during cold preservation hasvival.
Conclusions. The toxic effects observed in kidneys exposed been reported to last at least two weeks after transplanta-
to PEI 25k prevent any future possibility of their use in clinical tion [3, 4]. Normally, long-term expression of the trans-
transplantation. By contrast, adenovirus-mediated gene trans- gene is required if the final aim is to cure a disease. Byfer to the kidney offers exciting perspectives for the future of
contrast, in the context of strategies to minimize acutetransplant medicine. Transducing the graft with a gene encod-
rejection of organ transplants, long-term expression ofing CTLA4Ig effectively prolongs renal graft survival and in-
duces sustained unresponsiveness to the donor antigens with- the gene product appears less important providing that
out the need of immunosuppression. at least in the short term the gene is expressed in appro-
priate amounts in the very cell of interest.
Here we first attempted to enhance the transfection
Acute rejection of vascularized grafts can be success- efficiency of the non-viral system of gene delivery to
fully prevented by current medications at the expense, the kidney before transplantation. To this purpose, we
however, of an increased risk of infection and cancer exposed the kidney to PEI 25k complexed with a re-
[1]. To overcome systemic immunosuppression one can porter gene by a perfusion procedure, but this resulted
in a toxic effect to the point that the kidney could not
be reperfused after transplantation. We therefore movedKey words: gene transfer, renal transplantation, adenovirus, cationic
polymer, -galactosidase, CTLA4Ig. to a viral system employing an adenovirus encoding-gal
as being more likely to succeed. Finally, we investigated 2002 by the International Society of Nephrology
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whether ex-vivo transfection of the donor kidney with an diate-early enhancer/promoter region (Clontech, Palo
Alto, CA, USA).adenovirus encoding murine CTLA4Ig, would prolong
allograft survival. PEI 25k/DNA complexes were used with different
nitrogen (PEI 25k)/phosphate (DNA) charge ratios (10:1,
5:1, 2.5:1) and prepared as previously described [2].
METHODS
The replication deficient adenoviral vector containing
Animals the cDNA for the E. coli lacZ gene coding for the enzyme
-galactosidase was obtained according to a techniqueAdult male Lewis rats (Charles River Italia Spa, Calco,
Italy) weighing 200–250 g were used. Animal care and previously described [6]. The adenoviral vector Adm-
CTLA4Ig contains an expression cassette encoding thetreatment were conducted in accordance with national
and international laws and policies (European Economic murine CTLA4 gene coupled to the mouse immunoglob-
ulin sequence, replacing the viral E1 region and most ofCommunity Council Directive 86/609, OJL 358, Decem-
ber 1987; NIH Guide for the Care and Use of Laboratory the E1B region, rendering the virus replication-defective.
The construction and propagation of the vector was pre-Animals, U.S. National Research Council, 1996). All
animals were allowed free access to standard rat chow viously described [7].
and tap water.
-galactosidase quantification assay and histochemistry
Experimental design -galactosidase was quantified employing a lumines-
cent -gal detection kit (Clontech). The kidney was cutTo enhance the transfection efficiency of the cationic
polymer PEI 25k (Aldrich Chemical Company, Milwau- into small pieces, homogenized in 3 mL lysis buffer and
centrifuged at 14,000 rpm for 30 min at 4C in a microcen-kee, WI), the left kidney from a donor rat was isolated
in situ and perfused with an artificial cell-free medium trifuge; -gal activity of the supernatant was measured
in a single-well luminometer (Berthold Lumat LB 9507,[5]. PEI 25k/DNA (pCMV-galactosidase) complexes at
different ratios (10:1; 5:1; 2.5:1 in 10 mL of a 0.9% NaCl Bad Wildbad, Germany) for 10 seconds. Results were
expressed as RLU/kidney. -galactosidase histochemis-solution) were infused directly into the renal artery (N 
3 for each PEI 25k/DNA ratio), then perfusion at 4C try was previously described [8].
started and lasted one hour. Perfused kidney was then
Histologyremoved and transplanted into a syngeneic animal that
was killed two days after transplantation. As a control Kidney specimens were fixed for 6 hours in Dubosq-
Brazil, and dehydrated in alcohol. After paraffin embed-group donor kidneys (N  3) were perfused with the
medium alone. ding, 3-m sections of the blocks were cut and hematoxy-
lin eosin counterstaining was done.In a second set of experiments, the kidney was instead
perfused with the adenoviral vector carrying the -gal Immunohistochemical analysis for ED1 antigen, MHC
class II antigen, CD4, and CD8 cell surface glycoprotein,cDNA (1  109 pfu) before syngeneic transplantation.
Gene transfer was evaluated 2, 7 and 14 days after graft- was performed as previously described [9].
ing (N 3 for each time) by -gal histochemistry, chemi-
Analyticalsluminescence, and by -gal in situ hybridization at 2
and 14 days. A control group of animals (N  3) was Creatinine was measured by a Reflotron creatinine
test (Boehringer Mannheim) on whole blood collectedtransplanted with a kidney perfused as above with saline
(control). from the tail vein of anesthetized animals [10]. Protein-
uria was determined in 24 hour urine by the modifiedIn a third set of experiments, kidney allograft was
performed in high responder combination of Brown Nor- Coomassie blue G dye-binding assay for proteins with
bovine serum albumin as standard [11].way (BN, RT.1n) to Lewis (RT.11). Donor left kidneys
were injected through the renal artery with 150 L solu- Mixed lymphocyte reaction was performed as pre-
viously described [9, 12].tion containing: 1) the replication-deficient adenoviral
construct AdmCTLA4Ig (1.7 109 pfu, N 6), or 2) the
Statistical analysisreplication-deficient adenovirus encoding the reporter
gene -galactosidase (Ad-gal, 1  109 pfu, N  5), or Results are expressed as mean  SE. RLU/kidney
were log transformed before statistical analysis. Data3) saline (controls, N  5). After 30 minutes incubation
at 4C, kidneys were transplanted in a Lewis recipient were analyzed by ANOVA and multiple comparisons
between groups were done using Dunnett’s test. Survivalrat. Animals were followed for survival.
data were analyzed by PROC LIFETEST of SAS 6.12
Vectors and multiple comparisons between groups assessed by
LOG-RANK test. The statistical significance was definedPlasmid pCMV carries the E. coli -gal coding region
under the control of the cytomegalovirus (CMV) imme- as P  0.05.
Benigni et al: Gene delivery in renal transplantation S-117
Fig. 1. Representative photomicrographs of kidney after ex vivo perfusion prior to transplantation with PEI 25k at a PEI/DNA ratio of 5:1. (a,
b ) The photographs show severe structural damage to glomerular and tubular structures including cellular debris in the Bowman’s space and
glomerular and tubular cell lysis, thrombosis of a renal artery (H&E, 200).
Table 1. Chemiluminescence quantification of -gal activity intense at day 14. X-gal staining was consistent with data
in the homogenate of kidney perfused with Ad-gal or saline
from in situ hybridization, with the expression of the(control) at different times (2, 7 and 14 days) after
signal mainly localized into the cytoplasm of proximaltransplantation in syngeneic animals
and distal tubular cells (Fig. 2a). Mild staining was ob-RLU/kidney
served in the right kidney (Fig. 2b), and in the liver and
Control 2.31061.3106
lung [8]. No evidence of inflammatory infiltration wasDay 2 5.21073.9107
found in the kidney sections from control animals killedDay 7 2.91081.5108a
Day 14 3.11081.3108a on day 2. By contrast, mild infiltration of mainly mono-
a P  0.05 vs control cytes/macrophages in the interstitium was observed at
days 7 and 14.
To evaluate any negative impact on the renal function
RESULTS by the perfusion procedure, diuresis and serum creati-
Perfusion with polycations nine were evaluated in nephrectomized animals receiv-
ing a kidney perfused with the Ad-gal vector. DiuresisKidneys perfused with PEI 25k/DNA complexes were
increased on the second day after surgery (34  9.2transplanted in a syngeneic animal. Immediately after
mL/24 h) but returned to normal values on day 7 (12 completion of the vascular anastomosis, kidneys showed
2.31 mL/24 h vs 17  1.73 mL/24 h in control animals).large areas of hypoperfusion which lasted until the ani-
Serum creatinine concentration increased on day 1 (1.25mal was killed. The macroscopical observations were
0.2 mg/dL) and returned to normal values on day 7paralleled by renal histology findings showing injured
(0.64  0.08 mg/dL vs. 0.96  0.01 mg/dL in controlglomeruli and tubuli, capillary thrombosis (Fig. 1) and
animals). Proteinuria had the same trend, increasing onaccumulation of C3 in the glomerular capillaries (data
day 1 after grafting (25.05  0.2 mg/day) and droppingnot shown). Reperfusion of the kidney was achieved
by day 7 (9.85 3.8 mg/day vs. 8.9 2.3 mg/day in controlby lowering the PEI/DNA ratio to 2.5:1 ratio but no
animals).detectable transfection was observed.
AdmCTLA4Ig gene tranferAdenovirus mediated gene delivery
In AdmCTLA4Ig allografted animals, serum creati-Successful transfection was obtained in the left kidney
nine was 3.04  0.82 mg/dL at 7 days and slowly de-of animals perfused with 1  109 pfu of Ad-gal and
creased thereafter, despite the animal, which survivedtransplanted in a syngenic animal. -gal expression in-
longer, had still some degree of renal dysfunction at 95creased over controls from day 2 after grafting reaching
days (day 35: 2.5  0.6 mg/dL, N  5; day 50: 2.5  0.8a statistical significance on days 7 and 14 (P  0.05,
mg/dL, N  4; day 75: 2.2 mg/dl, N  2; day 95:1.6 mg/Table 1). In situ hybridization data with an antisense
dL). AdmCTLA4Ig allografted animals developed mildoligonucleotide probe for E.coli -gal, showed the pres-
proteinuria averaging 50  1 mg/day at day 45 withence of -gal mRNA in proximal and distal tubular cells
respect to the value of syngeneic animals receiving[8]. No staining for -gal mRNA was observed in control
AdmCTLA4Ig that was 16  3 mg/day at the same timeanimals receiving saline. -gal mRNA expression was
period. Protein excretion rate did not show any furtherdetectable in kidneys perfused with the virus and sacri-
fied at day 2 after transplantation, and became more increase in long term surviving animals. In AdmCTLA4Ig
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Fig. 2. Detection of -gal activity 7 days after transplantation of left kidney perfused with an adenoviral vector encoding for -gal. a) Photomicro-
graph of a kidney graft section showing -gal cytoplasmic staining of proximal and distal tubular cells (400) In this animal, few parietal epithelial
glomerular cells were positive for -gal. b ) Right controlateral kidney with only faint tubular staining (200).
stimulator cells either in Ad-gal or AdmCTLA4Ig
treated animals (20.1  1.2 vs. 10.8  0.9, respectively).
To evaluate whether adenovirus, per se`, could induce
parenchymal injury or leukocyte infiltration, analysis of
mononuclear cell subpopulations was performed in trans-
planted animals receiving Ad-gal or AdmCTLA4Ig
vector. The number of infiltrating cells was significantly
higher in syngeneic transplanted animals (P 0.01) than
in controls. Compared with syngeneic animals—whose
parenchymal infiltration of inflammatory cells can be
attributed solely to the inflammatory response against
viral protein—in allografted animals receiving Adm-
CTLA4Ig the absolute amount of CD4, CD8 and
dendritic cells was higher, despite the fact that no signs
of vasculitis and tubulitis characteristic of rejecting grafts
were observed (data not shown).
DISCUSSION
In the present paper we showed that in kidneys per-
Fig. 3. Survival of renal allografts. Data represents the mean survival fused ex vivo with PEI 25k and subsequently trans-
time (days) obtained in each group of animals. Survival was significantly planted into syngeneic animals, the initial reperfusionprolonged in rats receiving AdmCTLA4Ig-transduced graft (N  6;
was absent. Renal pathology showed diffuse intravascu-*P  0.01) over those receiving Ad-gal (N  5) or saline (N  5)
treated graft. lar coagulation and complement deposition possibly due
to the capacity of the synthetic cations to activate such
a cascade pathway [13]. At a low cation polymer/DNA
ratio, the reperfusion of the graft was complete, withanimals, survival was prolonged respect to control groups
appreciable post-transplant diuresis but none of the(Fig. 3, P  0.01 vs. Ad-gal group and saline group,
transplanted kidneys had any evidence of gene transfer.respectively: 57.3 24.3 vs. 6.6 0.5 and 7.4 0.5 days).
Thus, gene delivery to the kidney with PEI 25k, althoughTo see whether AdmCTLA4Ig treatment could induce
theoretically attractive, shows insurmountable limita-systemic unresponsiveness, the proliferative response of
tions, possibly due to their properties of activating theT cells from long term survivors was evaluated by MLR
complement system. These studies indicate that in thein vitro experiments. The stimulation index of AdmCTLA-
context of organ transplantation, the toxicity of cationic4Ig-transduced allografted animals was significantly lower
polymers is such that their chance to be used in humanthan that of control rats transduced with Ad-gal (P 
studies is remote.0.01; 4.1  0.3 vs. 13.1  0.6). The proliferative response
was still high in respect to third-party (Sprague Dawley) In order to explore more realistic alternatives for a
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possible use in clinical transplantation, we moved to viral vival of kidney allografts. Studies should now address
technique. After perfusion with the adenoviral vector, all whether—as in rodents—large animals can be trans-
transplanted kidneys reperfused normally, with prompt fected by the above approach, and effectively enough
diuresis, acquired normal function within few days and for true control of intragraft immunity. If organ gene
expressed the transgene. Expression of the transfected transfer will prevent rejection in primates without the
gene mainly in the cytoplasm of tubular epithelial cells need of immunosuppression, the future of human trans-
renders genetic manipulation of the kidney an attractive plant medicine will change substantially.
approach to the modulation of acute rejection since the
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